Pulmatrix

Cequent Pharmaceuticals, a privately held biopharmaceutical company based in Cambridge, Massachusetts, is at the forefront of developing novel therapeutics aimed at preventing and treating a variety of human diseases, including inflammatory diseases and cancer. Established in 2006, the company leverages its proprietary TransKingdom RNA interference (tkRNAi) technology to target specific disease-causing genes safely and effectively using non-pathogenic bacteria as delivery vehicles. The tkRNAi platform enables the development of drug candidates that can silence one or more cellular genes simultaneously, offering a powerful alternative to traditional small molecules and monoclonal antibodies. With its foundation rooted in groundbreaking scientific research from the Institut Pasteur in Paris and Beth Israel Deaconess Medical Center at Harvard Medical School, Cequent is poised to make significant advancements in the biopharmaceutical landscape. Generated from the website

DownStream Technologies, based in Marlborough, MA, specializes in manufacturing data preparation solutions for printed circuit board (PCB) design. Their innovative products, including CAM350, DFMStream, and BluePrint-PCB, offer advanced functionality to enhance visualization, verification, and documentation throughout the PCB design cycle. The company is committed to redefining the post-processing landscape for engineering professionals by providing comprehensive tools for producing complete PCB assembly release packages. With a focus on integrating design-to-manufacturing workflows, DownStream Technologies aims to support its clients with superior solutions and resources. Generated from the website

Lonza Biologics is a chemical and biotechnology company driven by the life sciences Lonza is one of the leading custom manufacturers of chemical intermediates, active ingredients and biopharmaceuticals for the pharmaceutical and agrochemical industries. On the basis of organic chemical, oleochemical and biotechnology platforms, the company creates value-added solutions for the nutrition; hygiene and personal care; wood and water treatment; and industrial specialty markets. It also offers polymer intermediates, resins and compounds. Lonza Biologics maintains its headquarters in Switzerland, and operates 18 production and research and development sites throughout the world, including a location in Newington, N.H.